Stock kasuwa, musayar ciniki a yau
Rahoton samfurori na kamfanonin 71229 a ainihin lokacin.
Stock kasuwa, musayar ciniki a yau

Rahoton samfurori

Stock ya faɗi a kan layi

Stock ya faɗi tarihi

Kasashen kasuwancin jari

Stock dividends

Riba daga kamfanin kamfanoni

Rahotan kuɗi

Ƙididdiga na kamfanoni. A ina zan zuba kudi?

Dividends Astellas Pharma Inc.

Dates na biyan kuɗi a kan hannun jari na ALPMF, tarihin ƙididdiga na Astellas Pharma Inc. da shekaru, rarraba yawan amfanin gonar Astellas Pharma Inc. a shekara ta 2024. Shin Astellas Pharma Inc. biya bashin? Menene rabon da Astellas Pharma Inc. ya biya?
Ƙara zuwa widget din
Ƙara zuwa widget din

Yaushe Astellas Pharma Inc. biya bashin?

Astellas Pharma Inc. tana ba da gudummawa ga 2 sau a shekara, biyan kuɗin da aka bayar a kan hannun jari na ALPMF shine 27/09/2019.

Menene rabon da Astellas Pharma Inc. ya biya?

Kamfanin Astellas Pharma Inc. ya biya farashin 20 $ a kowane lokaci kuma yawan kuɗin da aka samu a shekara ta 280.62 %.

Yaushe ne kwanan farashin biyan kuɗi na gaba na gaba Astellas Pharma Inc.?

An kiyasta kudaden biyan kuɗi na gaba na Astellas Pharma Inc. ranar Maris 2025.

Rarrabawa - wannan shine babbar hanyar samun kuɗaɗen masu saka jari daga hannun hannun jari na kamfanin. Kwanan wata da girma na biyan hannun jari sun dogara da ayyukan kamfanin ne ba koyaushe ake iya faɗi ba. Sabis ɗinmu yana nuna tarihin rarrabuwar kuɗaɗen Astellas Pharma Inc. da kintace don biyan rabon. Don kwanakin biyan kuɗi daban-daban, jadawalin rarrabuwa na Astellas Pharma Inc. yana jawo shafin nasa.

Nuna:
To

Dividends Astellas Pharma Inc. tarihin biyan kuɗi

Yawan kuɗin da aka karɓa a cikin hanyar rabawa daga hannun jari ya dace da tsawo na ginshiƙi ginshiƙi. Astellas Pharma Inc. ginshiƙi mai rarrabawa ya nuna canji a yawan biyan a kwanakin da aka biya na karshe. Jadawalin rabe-raben da aka karɓa ta Astellas Pharma Inc. a cikin 'yan shekarun nan an nuna shi a saman shafin sabis ɗinmu na rarrabawa. Jadawalin rarrabuwa tsakanin kungiyar Astellas Pharma Inc. yana nuna sabon adadin biyan kuɗi ne kawai. Akwai ƙarin bayani a cikin tebur.

Dividend payout kwanakin Astellas Pharma Inc.

Kwanan don biyan abubuwan rarrabawa a kan ALPMF an gabatar dasu a tebur ɗin sabis na kan layi. Teburin biyan kuɗi mai sauƙi ne: kowace ranar biya ana nuna ta azaman layi daban. Kwanan kwanan biyan kuɗi mafi girma Astellas Pharma Inc. yana kan layi na farko na tebur. Adadin kuɗaɗen harajin Astellas Pharma Inc. yana cikin shafi na biyu na teburin rarrabawa.

Kwanan kuɗin biyan kuɗi a kan hannun jari na ALPMF Adadin biya
Adadin biyan kuɗi da kashi.
Ƙididdigar rabawa
Sakamakon rabawa shine rabo daga adadin kudaden da aka biya a kowace shekara a darajar ɗaya.
27/09/2019 20 USD 280.62%
29/03/2019 19 USD 258.15%
28/09/2018 19 USD 330.13%
26/09/2018 0.17 USD 2.84%
28/03/2018 18 USD 363.82%
27/09/2017 18 USD 278.48%
29/03/2017 17 USD 254.06%
28/09/2016 17 USD 216.18%
29/03/2016 16 USD 238.49%
28/09/2015 16 USD 252.17%
27/03/2015 16 USD 191.85%
26/09/2014 14 USD 193.24%
27/03/2014 11.16 USD 184.64%
26/09/2013 65 USD 1 265.820%
27/03/2013 65 USD 1 198.870%
29/03/2011 65 USD 859.5%
28/09/2010 54 USD 750.63%

An kirga rabon kamfanin bisa ga kashi 1 na Astellas Pharma Inc.. Kudin don nuna adadin kudin da aka biya shine Astellas Pharma Inc. - dollar. Rarraba yawan amfanin ƙasa Astellas Pharma Inc. shine rabo na adadin rabon da aka biya a kowace shekara akan darajar kashi ɗaya. Yawan rarar kudin Astellas Pharma Inc. hannun jari yanzu suna cikin hidimarmu ta kan layi - 280.62 %.

Rarraba yawan amfanin ƙasa Astellas Pharma Inc. ita ce alama ta farko ga mai saka jari, ƙimar farashin hannun jari ita ce ta biyu. Bibiya dukkan awo a ayyukanmu na kan layi. Tarihin Astellas Pharma Inc. yawan amfanin ƙasa shine babban abin nuna alamar nasarar kamfanin a cikin dogon lokaci. Tarihin rarraban rabo na ƙarshe don 20 biya an nuna shi a cikin Astellas Pharma Inc. tebur na yawan amfanin ƙasa. Karshen rarar kayan masarufi na Astellas Pharma Inc. za'a iya gani a cikin babban layin tebur.

Kudin hannun jari Astellas Pharma Inc.

Finance Astellas Pharma Inc.